ARCHIVES

RFA: Clinical Correlative Studies In Solid Tumors

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Full Clearinghouse To Meet; Members Reveal Interests In Evaluations

October 28, 1977

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

No Controversy Over Cancer Act This Time

May 25, 1990